1) carbonic anhydrase inhibitor
碳酸酐酶抑制剂
1.
Advance in sulfonamides as carbonic anhydrase inhibitors;
磺胺类碳酸酐酶抑制剂研究进展
2.
Carbonic anhydrase inhibitors (CAIs) can decrease the generation of the aqueous humor by inhibiting the secretion of it, reducing the intraocular pressure for treatment of glaucoma.
碳酸酐酶抑制剂 (CAIs)可抑制房水分泌而减少房水的生成 ,从而起到降眼压、治疗青光眼的作用。
3.
Fifty-six patients in group 1 were treated with a beta-blocker as monotherapy; 36 patients in group 2 were treated with an alpha-adrenergic agonist as monotherapy; 48 patients in group 3 were treated with a beta-blocker in conjunction with a carbonic anhydrase inhibitor (CAI); 35 patients in group 4 were treated with an alpha-agonist,also in conjunction with CAI.
第1组56例(56眼),单一应用β阻滞剂;第2组36例(36眼),单一应用α激动剂;第3组48例(48眼),协同应用β阻滞剂与碳酸酐酶抑制剂;第4组35例(35眼),协同应用α激动剂与碳酸酐酶抑制剂。
2) carbonanhydrase inhibitor
碳酸脱水酶抑制剂
3) Carbonic anhydrase
碳酸酐酶
1.
Clinical significance of erythrocyte carbonic anhydrase concentration in different thyroid diseases;
甲状腺疾病红细胞碳酸酐酶测定的临床意义
2.
Activity changes of Na~+,K~+-ATPase and carbonic anhydrase of ciliary body after traumatic anterior proliferative vitreoretinopathy of the rabbit’s eye;
兔眼外伤性前部PVR睫状体Na~+,K~+-ATP酶和碳酸酐酶活性改变
4) Carbonic anhydrase II (CA II)
碳酸酐酶II
5) carbonic anhydrase Ⅲ
碳酸酐酶Ⅲ
1.
Aim: To detect carbonic anhydrase Ⅲ (CA Ⅲ) and its antibody in sera of myasthenia gravis (MG), and to explore whether or not the CA Ⅲ protein which was deficient in skeletal muscles of myasthenia gravis (MG) was involved in the immuno-pathogenesis of MG.
目的:检测重症肌无力(MG)患者血清中碳酸酐酶Ⅲ(CAⅢ)及其抗体水平,探讨MG骨骼肌减少的CAⅢ是否参与MG的免疫发病。
6) Carbonic anhydrasse
碳酸酐酶类
补充资料：碳酸酐酶抑制剂
碳酸酐酶抑制剂
一类能抑制碳酸酐酶活性的药物，如乙酰唑胺等。碳酸酐酶存在于人体肾皮质小管细胞、红细胞、胃粘膜、眼及中枢神经细胞中。其主要作用是促使 CO2+H2O-H2CO3。当碳酸酐酶活性降低时，各种需要大量及连续供应H+及 HCO3-的机能都将受到影响。如乙酰唑胺抑制肾小管的碳酸酐酶后，H+产生减少，导致利尿，但作用很弱。而睫状体细胞的碳酸酐酶可能与房水的形成有关，乙酰唑胺能使房水的生成减少，降低眼内压。目前这类药物主要用于治疗青光眼。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条